Patients should visit a cardiologist (preferably within 3 months) to reassess any potential changes in their risk situation, including clinical assessment of lifestyle modification measures, adherence to the target risk factors, and new comorbidities that could affect treatment and results. |
I |
C |
In patients with mild or no symptoms in whom non-invasive risk stratification indicates high risk and for whom revascularization could improve prognosis, invasive coronary angiography is recommended (FFR, when necessary and available). |
I |
C |
Risk stratification by stress imaging can be performed in high-risk patients approximately 6 months after revascularization. |
IIb |
C |
A new angiography may be considered in high-risk revascularization patients (e.g., unprotected left main coronary artery disease), regardless of the symptoms. |
IIb |
C |
Routine stress imaging should be performed in patients who were revascularized percutaneously > 1 year or surgically > 5 years. |
IIb |
C |
CCTA alone can be used for routine stratification. |
III |
C |
Coronary angiography alone can be used for risk stratification in an asymptomatic patient. |
III |
C |
Asymptomatic patients |
Evaluate coronary disease status in patients who have impaired LV systolic function with no identifiable cause. |
I |
C |
Perform stress imaging (preferably) in patients with new symptoms and/or worsening symptoms. |
I |
C |
Perform angiography (with FFR or iFR, if necessary) in patients with unmistakable symptoms of coronary disease, especially if it is refractory to drug treatment or if they fit the high-risk profile. |
I |
C |
Perform angiography in patients with high-risk stress imaging findings. |
I |
C |
In a previously revascularized patient, stress imaging should be performed rather than ET. |
IIa |
C |